Macrolide-Resistant <i>Mycoplasma pneumoniae</i> in Children, Ohio, USA
As the COVID-19 pandemic waned, Mycoplasma pneumoniae reemerged in the pediatric population in Ohio, USA. The rate of macrolide-resistant M. pneumoniae fluctuated by month, ranging from 0 to 8.7%, and mirrored the azithromycin prescribing rate. Real-time surveillance for macrolide-resistant M. pneumoniae provides accurate information for management of children with these infections.
Authors
- Amy L. Leber (ORCID: https://orcid.org/0000-0002-3075-3586)
- Jeanette Taveras
- H Wang
- Marcell Székely (ORCID: https://orcid.org/0000-0002-3108-5065)
- Sophonie J. Oyeniran (ORCID: https://orcid.org/0000-0001-9372-3491)
- Tori Embry
- Kathy Everhart
Publication Details
- Journal
- Emerging infectious diseases
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3201/eid3112.251008
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35